Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Vanderbilt Start up SkyNano wins 2020 R&D100 Award
There have been 19 US Patents issued in FY21.
Grant from Google to support COVID gene expression study
Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern.
There have been 10 U.S. Patents issued in FY21.
Antibody research at Vanderbilt University Medical Center shows promise in fight against COVID-19
The Vanderbilt Institute for Infection, Immunology and Inflammation (VI4) recently moved into its new research and administrative home.
VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial
Discovery of natural compound may help fend off antibiotic resistance of hard-to-treat infections